Heart failure & cardiomyopathies

Systemic Immune-Inflammation Index as a Prognostic Marker for Advanced Chronic Heart Failure with Renal Dysfunction

ESC Heart FailPublished Retrospective cohort study

Authors' conclusion

This study suggested that SII is a novel independent predictor of mortality in advanced chronic heart failure patients with renal dysfunction

Study context

Population
Advanced chronic HF patients with renal dysfunction, First affiliated hospital of Zhengzhou University, September 2019 to December 2020
Participants
717 patients
Exposure
High SII vs low SII
  • High-SIIn = 238
  • Low-SIIn = 479reference
Outcome
All-cause mortality (ACM)
Follow-up
Within 30 months
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

ACM
Hazard ratio (95% CI)P value
High-SIIvs Low-SIImultivariate Cox; incidence increased by 70.3%
1.703(1.200–2.337)
P = 0.002
SIIunivariate Cox
2.144(1.565–2.938)
P < 0.001
Kaplan-Meier (K-M): higher risk of all-cause mortalities (ACM) with high SII within 30 months
log-rank P < 0.001

Observational data: associations, not effects.

Secondary outcomes

OutcomeHR (95% CI)P value
MACE (high-SII n = 203 vs low-SII n = 514; cut-off 1406)High-SIIvs Low-SIIMultivariate Cox; incidence increased by 58.3%1.583 (1.213–2.065)P = 0.001

MACE (high-SII n = 203 vs low-SII n = 514; cut-off 1406)

HR (95% CI)P value
SIIUnivariate Cox1.625 (1.261–2.905)P < 0.001
MACE (high-SII n = 203 vs low-SII n = 514; cut-off 1406) — K-M: higher risk of MACE with high SII within 30 months
log-rank P < 0.001

Original publication

Systemic Immune-Inflammation Index as a Prognostic Marker for Advanced Chronic Heart Failure with Renal Dysfunction. ESC Heart Fail. Published 31 October 2022. doi:10.1002/ehf2.14217

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.